Opportunity Information: Apply for CDC RFA GH16 1698
Apply for CDC RFA GH16 1698
- The HHS-CDC-CGH in the health sector is offering a public funding opportunity titled "Strengthening the Dominican Republic's National Health Services in the Areas of HIV and TB Information Systems and Delivery of HIV and TB Care and Treatment among Key Populations and Migrants under PEPFAR" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.067.
- This funding opportunity was created on Feb 07, 2016 and posted on Feb 07, 2016.
- Applicants must submit their applications by Apr 07, 2016. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $2,500,000.00 in funding.
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
This grant opportunity, titled "Strengthening the Dominican Republic's National Health Services in the Areas of HIV and TB Information Systems and Delivery of HIV and TB Care and Treatment among Key Populations and Migrants under PEPFAR," is a CDC-led cooperative agreement designed to support the Dominican Republic Ministry of Health (MOH) in improving national capacity for HIV and tuberculosis (TB) programming. It sits under PEPFAR and emphasizes both stronger health information systems and better, more consistent delivery of HIV and TB prevention, care, and treatment services, especially for key populations and migrants or other mobile groups who may face barriers to routine care.
The program is structured as a cooperative agreement (rather than a simple grant), which typically means CDC expects to have substantial involvement in technical direction, planning, monitoring, and evaluation. The intent is not only to fund activities, but also to strengthen national systems and quality standards so improvements are durable and can be scaled or sustained within the MOH framework. The announcement highlights a close partnership between CDC and the MOH, signaling that funded work should align with national strategies and be coordinated with government priorities and existing service delivery structures.
The technical focus areas named in the opportunity point to a comprehensive package of system strengthening and targeted service improvements. A central component is improving an HIV Patient Monitoring Information System, which generally refers to the tools and processes used to track patients across the HIV care continuum, such as enrollment, clinical visits, antiretroviral therapy initiation and adherence, laboratory monitoring, and retention in care. Strengthening this system can help facilities and the MOH produce more accurate and timely data, identify gaps like loss to follow-up, and support evidence-based decisions about where to concentrate resources.
Another major area is improving the Laboratory Quality Management System. This type of work usually includes standardizing laboratory procedures, strengthening quality assurance and quality control practices, supporting proficiency testing, improving documentation and biosafety practices, and building capacity for reliable testing that HIV and TB programs depend on. Because HIV viral load testing and TB diagnostics are foundational for treatment decisions and monitoring, improving laboratory quality directly affects patient outcomes and program credibility.
The announcement also includes mentoring and an HIV Rapid Testing Quality Improvement Initiative (RTQII). This suggests hands-on capacity building for providers and testing sites to ensure rapid HIV testing is performed correctly, results are accurate, and testing services follow national and international standards. Quality improvement approaches often involve training, supportive supervision, routine assessment of testing sites, corrective actions, and ongoing mentorship to reduce errors and improve consistency, especially in decentralized or high-volume testing environments.
TB-HIV coinfection is called out explicitly, reflecting the clinical and public health importance of integrated services for people affected by both conditions. Activities in this area commonly include strengthening screening and diagnostic referral pathways, ensuring timely linkage between TB and HIV services, improving coordination of treatment protocols, and reinforcing monitoring and reporting for coinfected patients. The aim is typically to reduce missed diagnoses, improve treatment initiation and completion, and lower morbidity and mortality among people living with HIV who are at increased risk for TB.
The opportunity also prioritizes services for mobile populations, which in the Dominican Republic context can include migrants and other groups who move frequently for work or other reasons. These populations often face legal, economic, language, and social barriers that can interrupt treatment and follow-up. The FOA indicates an intent to tailor service delivery approaches that improve access, continuity of care, and retention for people who may cross geographic or administrative boundaries. This can involve coordination across facilities, patient-held documentation approaches, targeted outreach, and referral systems designed for continuity rather than one-time contact.
Finally, the FOA includes conducting a Behavioral Surveillance Survey (BSS) among people living with HIV/AIDS (PLWH). A BSS typically collects structured information on behaviors, service access, risk factors, stigma and discrimination experiences, adherence challenges, and other social and behavioral determinants that influence health outcomes. Results from such a survey can guide program design by identifying barriers to care, gaps in prevention and support services, and opportunities for more effective communication and engagement strategies.
In terms of funding and administrative details, the opportunity number is CDC RFA GH16-1698, administered by HHS-CDC-CGH, and listed under CFDA 93.067 within the health activity category. The award ceiling is $2,500,000, with one expected award, indicating a single main implementing partner would likely be selected to carry out the core package of activities at national scale or across priority sites. The original and current closing date was April 7, 2016, and the opportunity was posted on February 7, 2016. Eligibility is described broadly as "Others (see text field entitled Additional Information on Eligibility for clarification)," which usually signals that applicants could include certain types of organizations beyond standard categories, depending on the FOA's detailed eligibility language.
Overall, the grant is aimed at strengthening the Dominican Republic's HIV and TB response by improving core systems (patient monitoring and lab quality), raising the quality of testing and clinical services through mentorship and quality improvement, addressing the complex needs of TB-HIV coinfected patients, extending effective care to migrants and other mobile groups, and generating behavioral data among PLWH to better tailor interventions. The combined focus on data systems, quality management, and service delivery suggests the program is intended to improve both day-to-day clinical performance and the national program's ability to measure results and respond quickly to gaps.
FAQs: Strengthening the Dominican Republic's National Health Services for HIV and TB (CDC RFA GH16-1698)
What is the title of this grant opportunity?
The opportunity is titled "Strengthening the Dominican Republic's National Health Services in the Areas of HIV and TB Information Systems and Delivery of HIV and TB Care and Treatment among Key Populations and Migrants under PEPFAR."
Which agency is leading this opportunity?
The opportunity is administered by HHS-CDC-CGH (Centers for Disease Control and Prevention).
What type of funding mechanism is this?
This is a CDC-led cooperative agreement. A cooperative agreement typically means CDC expects substantial involvement in areas like technical direction, planning, monitoring, and evaluation.
How does a cooperative agreement differ from a standard grant in this context?
Based on the description provided, the cooperative agreement structure signals close CDC involvement and collaboration with the Dominican Republic Ministry of Health (MOH), with an emphasis on coordinated planning, performance monitoring, and strengthening national systems rather than only funding stand-alone activities.
What is the overarching purpose of the program?
The program is intended to support the Dominican Republic MOH in improving national capacity for HIV and tuberculosis (TB) programming, with a strong emphasis on health information systems and consistent delivery of HIV and TB prevention, care, and treatment services.
Is this opportunity connected to PEPFAR?
Yes. The opportunity sits under PEPFAR and prioritizes system strengthening and service delivery improvements aligned to that context.
Who is the primary national partner referenced in the opportunity?
The Dominican Republic Ministry of Health (MOH) is identified as a key partner, and the work is described as closely coordinated with government priorities and national strategies.
What are the main technical focus areas mentioned?
The opportunity highlights: strengthening an HIV Patient Monitoring Information System, improving a Laboratory Quality Management System, mentoring and an HIV Rapid Testing Quality Improvement Initiative (RTQII), addressing TB-HIV coinfection through integrated approaches, improving services for migrants and other mobile populations, and conducting a Behavioral Surveillance Survey (BSS) among people living with HIV/AIDS (PLWH).
What does "strengthening an HIV Patient Monitoring Information System" involve?
As described, this component focuses on tools and processes used to track patients across the HIV care continuum, such as enrollment, clinical visits, ART initiation and adherence, laboratory monitoring, and retention in care, to improve data accuracy and timeliness and help identify gaps like loss to follow-up.
Why is improving the HIV Patient Monitoring Information System important?
The opportunity indicates that stronger patient monitoring supports more accurate and timely data, helps identify care gaps (including loss to follow-up), and enables evidence-based decisions about where to concentrate resources.
What is meant by improving the Laboratory Quality Management System?
This refers to strengthening laboratory procedures and quality practices, including standardization, quality assurance and quality control, proficiency testing support, better documentation, and biosafety practices to ensure reliable testing that HIV and TB programs depend on.
How do laboratory quality improvements connect to HIV and TB outcomes?
The description notes that HIV viral load testing and TB diagnostics are foundational for treatment decisions and monitoring, so improvements in laboratory quality directly affect patient outcomes and program credibility.
What is the HIV Rapid Testing Quality Improvement Initiative (RTQII) described here?
RTQII is presented as a quality improvement and mentoring approach to ensure rapid HIV testing is performed correctly, results are accurate, and testing services follow national and international standards through activities like training, supportive supervision, routine assessments, corrective actions, and ongoing mentorship.
What does the opportunity say about mentoring?
Mentoring is emphasized as hands-on capacity building for providers and testing sites, supporting consistent quality in HIV testing and related services, particularly in decentralized or high-volume environments.
Why is TB-HIV coinfection a priority area in this opportunity?
TB-HIV coinfection is highlighted due to its clinical and public health importance, with a focus on strengthening integrated services and improving screening, diagnosis pathways, linkage between TB and HIV services, and monitoring and reporting for coinfected patients.
What kinds of activities are implied for TB-HIV integration?
The description points to strengthening screening and diagnostic referral pathways, ensuring timely linkage across TB and HIV services, improving coordination of treatment protocols, and reinforcing monitoring and reporting to reduce missed diagnoses and improve treatment initiation and completion.
Which populations are specifically prioritized for improved service delivery?
The opportunity emphasizes key populations and migrants or other mobile groups who may face barriers to routine care, with tailored approaches to improve access, continuity, and retention.
What challenges do migrants and mobile populations face that this program aims to address?
The opportunity notes that migrants and mobile groups may face legal, economic, language, and social barriers that can interrupt treatment and follow-up, requiring service delivery approaches designed for continuity rather than one-time contact.
What approaches are suggested for improving continuity of care for mobile populations?
Examples mentioned include coordination across facilities, patient-held documentation approaches, targeted outreach, and referral systems designed to maintain continuity of care even when people move across geographic or administrative boundaries.
What is the Behavioral Surveillance Survey (BSS) and who is it conducted among?
The opportunity includes conducting a BSS among people living with HIV/AIDS (PLWH). The survey typically gathers structured information on behaviors, service access, risk factors, stigma and discrimination experiences, adherence challenges, and other social and behavioral determinants.
How are BSS results expected to be used?
The description indicates BSS findings can guide program design by identifying barriers to care, gaps in prevention and support services, and opportunities for more effective communication and engagement strategies.
What is the opportunity number for this funding?
The opportunity number is CDC RFA GH16-1698.
What is the CFDA number and category listed?
The listing includes CFDA 93.067 and is categorized under health.
What is the maximum (ceiling) award amount?
The award ceiling is $2,500,000.
How many awards are expected?
One award is expected, suggesting a single main implementing partner would likely be selected to carry out the core package of activities at scale.
When was this opportunity posted?
The opportunity was posted on February 7, 2016.
What was the application closing date?
The original and current closing date shown is April 7, 2016.
How is eligibility described?
Eligibility is described broadly as "Others (see text field entitled Additional Information on Eligibility for clarification)," indicating the eligible applicant types may extend beyond standard categories depending on the FOA's detailed eligibility language.
What does the opportunity suggest about alignment with national strategies?
It emphasizes close partnership between CDC and the MOH and indicates funded work should align with national strategies and be coordinated with government priorities and existing service delivery structures.
What is the overall intended impact of combining data systems, quality management, and service delivery?
The opportunity frames the combined focus as a way to improve day-to-day clinical performance while strengthening the national program's ability to measure results, identify gaps quickly, and respond effectively, with improvements designed to be durable and sustainable within the MOH framework.
Browse more opportunities from the same category: Health
Next opportunity: Delivering High Quality HIV Prevention, Care and Treatment Services in Barbados under the President's Emergency Plan for AIDS Relief (PEPFAR)
Previous opportunity: Mechanistic Ancillary Studies to Ongoing Interventional Clinical Trials (R01)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA GH16 1698
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA GH16 1698) also looked into and applied for these:
| Funding Opportunity |
|---|
| Delivering High Quality HIV Prevention, Care and Treatment Services in Barbados under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH16 1610 Funding Number: CDC RFA GH16 1610 Agency: HHS-CDC-CGH Category: Health Funding Amount: $350,000 |
| Delivering High Quality HIV Prevention, Care and Treatment Services in the Bahamas under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH16 1609 Funding Number: CDC RFA GH16 1609 Agency: HHS-CDC-CGH Category: Health Funding Amount: $500,000 |
| Models of Collaboration for State Chronic Disease and Oral Health Programs Apply for CDC RFA DP16 1609 Funding Number: CDC RFA DP16 1609 Agency: HHS-CDC-NCCDPHP Category: Health Funding Amount: $250,000 |
| Improving Coordination and Leadership of HIV/AIDS Programs in Ethiopia under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH16 1615 Funding Number: CDC RFA GH16 1615 Agency: HHS-CDC-CGH Category: Health Funding Amount: $3,000,000 |
| Delivery High Quality HIV Prevention, Care and Treatment Services in Trinidad and Tobago under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH16 1608 Funding Number: CDC RFA GH16 1608 Agency: HHS-CDC-CGH Category: Health Funding Amount: $600,000 |
| Strengthening Public Health Capacity and Strategic Information Systems through Cooperation and Support Services from the Joint United Nations Programme on HIV/AIDS (UNAIDS) under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH16 1617 Funding Number: CDC RFA GH16 1617 Agency: HHS-CDC-CGH Category: Health Funding Amount: $3,000,000 |
| Strengthening HIV/AIDS, STI and TB Laboratory Services in the Namibian Institute of Pathology (NIP) for Epidemic Control in Namibia under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH16 1641 Funding Number: CDC RFA GH16 1641 Agency: HHS-CDC-CGH Category: Health Funding Amount: $2,292,104 |
| Supporting the Caribbean Public Health Agency Research, Policy Development and Evaluation Unit (REPDU) to build/strengthen Strategic Information capacity in Caribbean countries under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH16 1611 Funding Number: CDC RFA GH16 1611 Agency: HHS-CDC-CGH Category: Health Funding Amount: $500,000 |
| Supporting the National School of Public Health (SPH) to Strengthen Human Resources for Health (HRH) in HIV Care and Treatment and Epidemiology in Angola under the President's Emergency Plan for Aids Relief (PEPFAR) Apply for CDC RFA GH16 1605 Funding Number: CDC RFA GH16 1605 Agency: HHS-CDC-CGH Category: Health Funding Amount: $200,000 |
| Strategic Prevention Framework - Partnerships for Success (SPF-PFS) Apply for SP 16 003 Funding Number: SP 16 003 Agency: HHS-SAMHS Category: Health Funding Amount: $1,230,000 |
| Pre-application: Stimulating Peripheral Activity to Relieve Conditions (SPARC): Technologies to Understand the Control of Organ Function by the Peripheral Nervous System (OT1) Apply for RFA RM 16 002 Funding Number: RFA RM 16 002 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
| Sudden Death in the Young (SDY) Registry Apply for CDC RFA DP14 140303CONT16 Funding Number: CDC RFA DP14 140303CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| Limited Competition - Stimulating Peripheral Activity to Relieve Conditions (SPARC): Technologies to Understand the Control of Organ Function by the Peripheral Nervous System (OT2) Apply for RFA RM 16 003 Funding Number: RFA RM 16 003 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
| Reducing Nosocomial and Community-Acquired Tuberculosis by Strengthening the Capacity of the South Africa Department of Health to Improve Implementation of Infection Control and Waste Management at all Levels of the Health System under PEPFAR Apply for CDC RFA GH16 1644 Funding Number: CDC RFA GH16 1644 Agency: HHS-CDC-CGH Category: Health Funding Amount: $2,000,000 |
| Provision of HIV/AIDS-related Strategic Information and Laboratory Support and Technical Assistance Services in Angola under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH16 1604 Funding Number: CDC RFA GH16 1604 Agency: HHS-CDC-CGH Category: Health Funding Amount: $850,000 |
| Supporting the Implementation, Expansion, Sustainability, and Ownership of High Quality HIV Services in Siaya County in the Republic of Kenya under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH16 1691 Funding Number: CDC RFA GH16 1691 Agency: HHS-CDC-CGH Category: Health Funding Amount: $3,000,000 |
| Telehealth Network Grant Program Apply for HRSA 16 012 Funding Number: HRSA 16 012 Agency: HHS-HRSA Category: Health Funding Amount: Case Dependent |
| Service Area Competition – Additional Area (SAC-AA) – St. Paul (Island), Alaska Apply for HRSA 16 167 Funding Number: HRSA 16 167 Agency: HHS-HRSA Category: Health Funding Amount: Case Dependent |
| Ebola Containment and Prevention Equipment Grant Apply for CDC RFA GH15 163302CONT16 Funding Number: CDC RFA GH15 163302CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| Rapid Response to Ebola Viral Disease in West Africa through Strengthening of Surveillance Systems and Disruption of Chain of Transmission Interventions Apply for CDC RFA GH15 162902CONT16 Funding Number: CDC RFA GH15 162902CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA GH16 1698", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.